Chiesi USA, Inc. v. Aurobindo Pharma USA, Inc. > Documents

Date Field	Doc. No.	Description (Pages)
Dec 4, 2022	0	CHIESI USA, INC. v. AUROBINDO PHARMA USA, INC. [ORDER] [nonprecedential] (0)
Nov 29, 2022	4	ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [3] filed by Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. and Appellees Chiesi USA, Inc. and Chiesi Farmaceutici S.p.A..; issuing mandate. Service as of this date by the Clerk of Court. [887019] [ALK] [Entered: 11/29/2022 04:25 PM] (2)
Nov 22, 2022	3	MOTION of Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. and Appellees Chiesi Farmaceutici S.p.A. and Chiesi USA, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 11/22/2022 by email. [886066] [23-1171] [Steven Moore] [Entered: 11/22/2022 01:33 PM] (4)
Nov 21, 2022	1	Appeal docketed. Received: 11/15/2022. [885399]Entry of Appearance is due on 12/05/2022. Certificate of Interest is due on 12/05/2022. Docketing Statement is due on 12/05/2022. Appellants' brief is due on 01/20/2023. [ALK] [Entered: 11/21/2022 11:42 AM] (44)
Nov 21, 2022	2	Entry of appearance for Steven J. Moore; James E. Nealon as counsel for Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.. Service: 11/21/2022 by email. [885515] [23-1171] [Steven Moore] [Entered: 11/21/2022 02:13 PM] (1)